S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.99 (+0.90%)
AAPL   116.62 (+1.36%)
MSFT   214.22 (+1.97%)
FB   283.29 (+2.23%)
GOOGL   1,597.95 (+0.86%)
AMZN   3,289.00 (+2.56%)
TSLA   424.44 (+0.99%)
NVDA   535.87 (+1.94%)
BABA   317.15 (+3.35%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   78.91 (-4.04%)
T   26.93 (-1.64%)
F   7.92 (-1.37%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.67 (+0.09%)
NIO   28.59 (+9.92%)
BA   155.29 (-3.44%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.99 (+0.90%)
AAPL   116.62 (+1.36%)
MSFT   214.22 (+1.97%)
FB   283.29 (+2.23%)
GOOGL   1,597.95 (+0.86%)
AMZN   3,289.00 (+2.56%)
TSLA   424.44 (+0.99%)
NVDA   535.87 (+1.94%)
BABA   317.15 (+3.35%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   78.91 (-4.04%)
T   26.93 (-1.64%)
F   7.92 (-1.37%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.67 (+0.09%)
NIO   28.59 (+9.92%)
BA   155.29 (-3.44%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.99 (+0.90%)
AAPL   116.62 (+1.36%)
MSFT   214.22 (+1.97%)
FB   283.29 (+2.23%)
GOOGL   1,597.95 (+0.86%)
AMZN   3,289.00 (+2.56%)
TSLA   424.44 (+0.99%)
NVDA   535.87 (+1.94%)
BABA   317.15 (+3.35%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   78.91 (-4.04%)
T   26.93 (-1.64%)
F   7.92 (-1.37%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.67 (+0.09%)
NIO   28.59 (+9.92%)
BA   155.29 (-3.44%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.99 (+0.90%)
AAPL   116.62 (+1.36%)
MSFT   214.22 (+1.97%)
FB   283.29 (+2.23%)
GOOGL   1,597.95 (+0.86%)
AMZN   3,289.00 (+2.56%)
TSLA   424.44 (+0.99%)
NVDA   535.87 (+1.94%)
BABA   317.15 (+3.35%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   78.91 (-4.04%)
T   26.93 (-1.64%)
F   7.92 (-1.37%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.67 (+0.09%)
NIO   28.59 (+9.92%)
BA   155.29 (-3.44%)
DIS   123.31 (-0.60%)
Log in
LON:SN

Smith & Nephew Share Forecast, Price & News

GBX 1,524.50
-12.00 (-0.78 %)
(As of 10/2/2020)
Add
Compare
Today's Range
1,500
Now: GBX 1,524.50
1,535
50-Day Range
1,450
MA: GBX 1,521.66
1,578.50
52-Week Range
1,055.01
Now: GBX 1,524.50
2,023
Volume1.41 million shs
Average Volume343,671 shs
Market Capitalization£13.35 billion
P/E Ratio34.18
Dividend Yield2.04%
BetaN/A
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. Additionally, it offers meniscal repair system. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Read More
Smith & Nephew logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74017646
Employees16,377

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.69 billion
Cash FlowGBX 39.90 per share
Book ValueGBX 570.40 per share

Profitability

Miscellaneous

Market Cap£13.35 billion
Next Earnings DateN/A
OptionableOptionable
GBX 1,524.50
-12.00 (-0.78 %)
(As of 10/2/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive SN News and Ratings via Email

Sign-up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Smith & Nephew (LON:SN) Frequently Asked Questions

How has Smith & Nephew's stock price been impacted by Coronavirus?

Smith & Nephew's stock was trading at GBX 1,506 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SN shares have increased by 1.2% and is now trading at GBX 1,524.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Smith & Nephew?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Smith & Nephew
.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a dividend on Wednesday, July 29th. Shareholders of record on Thursday, October 1st will be given a dividend of GBX 0.14 per share on Wednesday, October 28th. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, October 1st. The official announcement can be viewed at this link.
View Smith & Nephew's dividend history
.

What price target have analysts set for SN?

10 analysts have issued 1-year target prices for Smith & Nephew's stock. Their forecasts range from GBX 1,553 to GBX 2,090. On average, they expect Smith & Nephew's share price to reach GBX 1,782.25 in the next twelve months. This suggests a possible upside of 16.9% from the stock's current price.
View analysts' price targets for Smith & Nephew
.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

How do I buy shares of Smith & Nephew?

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Smith & Nephew's stock price today?

One share of SN stock can currently be purchased for approximately GBX 1,524.50.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of £13.35 billion and generates £4.69 billion in revenue each year. Smith & Nephew employs 16,377 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.smith-nephew.com.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.